NO20061788L - HIV-replikasjonshemmede purinderivater - Google Patents

HIV-replikasjonshemmede purinderivater

Info

Publication number: NO20061788L
Authority: NO; Norway
Prior art keywords: formula; radical; hiv replication; purine derivatives; compound
Prior art date: 2003-09-25

Application number

NO20061788A

Other languages

English (en)

Norwegian (no)

Inventor

Jan Heeres

Marc Rene De Jonge

Lucien Maria Henricus Koymans

Hendrik Maarten Vinkers

Frederik Frans Desire Daeyaert

Paulus Joannes Lewi

Paul Adriaan Jan Janssen

Ruben Gerardus George Leenders

Dirk Alfons Leo Vandenput

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-25

Filing date

2006-04-24

Publication date

2006-04-24

2006-04-24 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2006-04-24 Publication of NO20061788L publication Critical patent/NO20061788L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20061788A 2003-09-25 2006-04-24 HIV-replikasjonshemmede purinderivater NO20061788L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP0350659		2003-09-25
PCT/EP2004/052262 WO2005028479A2 (en)	2003-09-25	2004-09-21	Hiv replication inhibiting purine derivatives

Publications (1)

Publication Number	Publication Date
NO20061788L true NO20061788L (no)	2006-04-24

Family

ID=34354400

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20061788A NO20061788L (no)	2003-09-25	2006-04-24	HIV-replikasjonshemmede purinderivater

Country Status (19)

Country	Link
US (1)	US8026245B2 (pt)
EP (1)	EP1668011B1 (pt)
JP (1)	JP5506751B2 (pt)
KR (1)	KR20060121878A (pt)
CN (1)	CN100475815C (pt)
AP (1)	AP2006003517A0 (pt)
AT (1)	ATE500254T1 (pt)
AU (1)	AU2004274185B2 (pt)
BR (1)	BRPI0414791A (pt)
CA (1)	CA2535313C (pt)
DE (1)	DE602004031641D1 (pt)
EA (1)	EA009734B1 (pt)
ES (1)	ES2361835T3 (pt)
IL (1)	IL174467A0 (pt)
MX (1)	MXPA06002069A (pt)
NO (1)	NO20061788L (pt)
TW (1)	TW200518758A (pt)
WO (1)	WO2005028479A2 (pt)
ZA (1)	ZA200602440B (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI329105B (en)	2002-02-01	2010-08-21	Rigel Pharmaceuticals Inc	2,4-pyrimidinediamine compounds and their uses
SG176311A1 (en)	2002-07-29	2011-12-29	Rigel Pharmaceuticals	Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
JP4886511B2 (ja)	2003-07-30	2012-02-29	ライジェルファーマシューティカルズ，インコーポレイテッド	２，４−ピリミジンジアミン化合物による自己免疫疾患の治療または予防方法
EP1720877A4 (en) *	2004-03-02	2009-11-04	Neurogen Corp	ANALOGUES OF PURINS ARYL SUBSTITUTION
ATE540677T1 (de)	2004-08-25	2012-01-15	Ardea Biosciences Inc	S-triazolyl alpha mercaptoacetanilide als hemmer der reversen transkriptase von hiv
WO2007050087A1 (en)	2004-08-25	2007-05-03	Ardea Biosciences, Inc.	N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
EP2269610A3 (en)	2004-09-20	2011-03-09	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
WO2006034279A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as therapeutic agents
BRPI0515489A (pt)	2004-09-20	2008-07-29	Xenon Pharmaceuticals Inc	derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase
BRPI0515483A (pt)	2004-09-20	2008-07-22	Xenon Pharmaceuticals Inc	derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
WO2006034341A2 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
BRPI0515478A (pt)	2004-09-20	2008-07-22	Xenon Pharmaceuticals Inc	derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase
CA2580855A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
KR20080004550A (ko)	2005-03-30	2008-01-09	콘포마 세러퓨틱스 코포레이션	Ｈｓｐ９０-억제제로서 알키닐 피롤로피리미딘 및 관련유사체
CN101233135B (zh) *	2005-05-05	2012-10-03	阿迪亚生命科学公司	用作非核苷反转录酶抑制剂治疗人免疫缺陷病毒的二芳基-嘌呤、二芳基-氮杂嘌呤和二芳基-脱氮嘌呤化合物
BRPI0610824A8 (pt) *	2005-05-16	2017-04-04	Prometic Pharma Smt Ltd	Compostos derivados de purina, uso dos mesmos e composição contendo os referidos compostos
JP2009513563A (ja)	2005-06-03	2009-04-02	ゼノン・ファーマシューティカルズ・インコーポレイテッド	ヒトのステアロイル−ＣｏＡデサチュラーゼ阻害剤としてのアミノチアゾール誘導体
ES2651349T3 (es)	2005-06-08	2018-01-25	Rigel Pharmaceuticals, Inc.	Composiciones y métodos para la inhibición de la ruta JAK
US20070203161A1 (en)	2006-02-24	2007-08-30	Rigel Pharmaceuticals, Inc.	Compositions and methods for inhibition of the jak pathway
US8962643B2 (en)	2006-02-24	2015-02-24	Rigel Pharmaceuticals, Inc.	Compositions and methods for inhibition of the JAK pathway
EP2132211A4 (en) *	2006-11-09	2011-12-07	Ardea Biosciences Inc	4-CYANPHENYLAMINO-SUBSTITUTED BICYCLIC AND HETEROCYCLIC COMPOUNDS AS AN HIV HEMMER
MX2009008253A (es)	2007-01-31	2009-10-12	Vertex Pharma	Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
KR101411806B1 (ko)	2007-11-27	2014-06-24	아디아 바이오사이언스즈 인크.	신규한 화합물 및 조성물과 사용 방법
EP2220091B1 (en)	2007-12-14	2012-07-25	Ardea Biosciences, Inc.	Reverse transcriptase inhibitors
US8569337B2 (en)	2008-07-23	2013-10-29	Vertex Pharmaceuticals Incorporated	Tri-cyclic pyrazolopyridine kinase inhibitors
CA2731498A1 (en)	2008-07-23	2010-01-28	Vertex Pharmaceuticals Incorporated	Tri-cyclic pyrazolopyridine kinase inhibitors
CA2731451A1 (en)	2008-07-23	2010-01-28	Vertex Pharmaceuticals Incorporated	Pyrazolopyridine kinase inhibitors
CA2732765A1 (en)	2008-08-06	2010-02-11	Vertex Pharmaceuticals Incorporated	Aminopyridine kinase inhibitors
CN102459259A (zh)	2009-05-06	2012-05-16	沃泰克斯药物股份有限公司	吡唑并吡啶类
EP2499143B1 (en)	2009-11-12	2016-03-16	F.Hoffmann-La Roche Ag	N7-substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
CN102858769A (zh)	2010-01-27	2013-01-02	沃泰克斯药物股份有限公司	吡唑并吡啶激酶抑制剂
EP2550272A1 (en)	2010-01-27	2013-01-30	Vertex Pharmaceuticals Incorporated	Pyrazolopyrazine kinase inhibitors
WO2011094290A1 (en)	2010-01-27	2011-08-04	Vertex Pharmaceuticals Incorporated	Pyrazolopyrimidine kinase inhibitors
US20140018379A1 (en)	2010-02-18	2014-01-16	Concert Pharmaceuticals Inc.	Pyrimidine derivatives
FR2962437B1 (fr)	2010-07-06	2012-08-17	Sanofi Aventis	Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
FR2962438B1 (fr)	2010-07-06	2012-08-17	Sanofi Aventis	Derives d'indolizines, procedes de preparation et application en therapeutique
CN103570688B (zh) *	2012-07-19	2016-06-08	中国科学院上海药物研究所	2，5-二氨甲基吡嗪类化合物、其药物组合物、制备方法和用途
WO2015115673A1 (en)	2014-01-31	2015-08-06	Ono Pharmaceutical Co., Ltd.	Fused imidazole compounds
PL3235799T3 (pl)	2014-12-18	2022-05-02	Nissan Chemical Corporation	Związek oksymowy i herbicyd
CA3040286A1 (en)	2016-10-21	2018-04-26	Nimbus Lakshmi, Inc.	Tyk2 inhibitors and uses thereof
US20210380540A1 (en) *	2018-10-25	2021-12-09	Minakem	Process for the preparation of rilpivirine
CN110526873B (zh) *	2019-08-15	2022-09-16	复旦大学	氰乙烯基取代的苯并二芳基嘧啶类化合物及其制备方法和用途
CN114805369B (zh) *	2022-05-30	2023-05-16	自贡市第四人民医院(自贡市急救中心)	一种2，6-二取代嘌呤类化合物及制备方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3459731A (en)	1966-12-16	1969-08-05	Corn Products Co	Cyclodextrin polyethers and their production
NZ322907A (en)	1995-11-23	1998-12-23	Janssen Pharmaceutica Nv	Solid mixtures of cyclodextrins prepared via melt-extrusion
US5866702A (en) *	1996-08-02	1999-02-02	Cv Therapeutics, Incorporation	Purine inhibitors of cyclin dependent kinase 2
AU751573C (en)	1998-03-27	2003-10-09	Janssen Pharmaceutica N.V.	HIV inhibiting pyrimidine derivatives
EA004049B1 (ru) *	1998-11-10	2003-12-25	Янссен Фармацевтика Н.В.	Пиримидины, ингибирующие репликацию вич
US6414147B1 (en) *	1998-12-23	2002-07-02	Neurogen Corporation	2-amino-9-alkylpurines: GABA brain receptor ligands
CZ27399A3 (cs)	1999-01-26	2000-08-16	Ústav Experimentální Botaniky Av Čr	Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
GB9918035D0 (en) *	1999-07-30	1999-09-29	Novartis Ag	Organic compounds
CZ20022353A3 (cs)	2000-01-07	2003-02-12	Universitaire Instelling Antwerpen	Deriváty purinu, způsob jejich přípravy a jejich použití
JO3429B1 (ar)	2001-08-13	2019-10-20	Janssen Pharmaceutica Nv	مشتقات برميدينات مثبطة فيروس الايدز
US6897307B2 (en) *	2002-03-28	2005-05-24	Novartis Ag	Process for preparing 2,6-diaminopurine derivatives
JP2007502776A (ja) *	2003-08-15	2007-02-15	アイアールエム・リミテッド・ライアビリティ・カンパニー	Ｒｔｋ阻害剤としての６−置換アニリノプリン類
CN101233135B (zh) *	2005-05-05	2012-10-03	阿迪亚生命科学公司	用作非核苷反转录酶抑制剂治疗人免疫缺陷病毒的二芳基-嘌呤、二芳基-氮杂嘌呤和二芳基-脱氮嘌呤化合物

2004
- 2004-09-21 BR BRPI0414791-0A patent/BRPI0414791A/pt not_active Application Discontinuation
- 2004-09-21 AP AP2006003517A patent/AP2006003517A0/xx unknown
- 2004-09-21 DE DE602004031641T patent/DE602004031641D1/de not_active Expired - Lifetime
- 2004-09-21 CA CA2535313A patent/CA2535313C/en not_active Expired - Fee Related
- 2004-09-21 US US10/573,364 patent/US8026245B2/en not_active Expired - Fee Related
- 2004-09-21 EA EA200600648A patent/EA009734B1/ru not_active IP Right Cessation
- 2004-09-21 AU AU2004274185A patent/AU2004274185B2/en not_active Ceased
- 2004-09-21 MX MXPA06002069A patent/MXPA06002069A/es active IP Right Grant
- 2004-09-21 KR KR1020067005328A patent/KR20060121878A/ko not_active Application Discontinuation
- 2004-09-21 ES ES04766834T patent/ES2361835T3/es not_active Expired - Lifetime
- 2004-09-21 EP EP04766834A patent/EP1668011B1/en not_active Expired - Lifetime
- 2004-09-21 CN CNB2004800278401A patent/CN100475815C/zh not_active Expired - Fee Related
- 2004-09-21 AT AT04766834T patent/ATE500254T1/de not_active IP Right Cessation
- 2004-09-21 WO PCT/EP2004/052262 patent/WO2005028479A2/en active Application Filing
- 2004-09-24 TW TW093128936A patent/TW200518758A/zh unknown
2006
- 2006-03-21 IL IL174467A patent/IL174467A0/en active IP Right Grant
- 2006-03-24 ZA ZA200602440A patent/ZA200602440B/en unknown
- 2006-04-24 NO NO20061788A patent/NO20061788L/no not_active Application Discontinuation
2011
- 2011-08-01 JP JP2011168572A patent/JP5506751B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
TW200518758A (en)	2005-06-16
ES2361835T3 (es)	2011-06-22
ATE500254T1 (de)	2011-03-15
BRPI0414791A (pt)	2006-11-21
AU2004274185A1 (en)	2005-03-31
JP4825672B2 (ja)	2011-11-30
EA200600648A1 (ru)	2006-08-25
EP1668011A2 (en)	2006-06-14
DE602004031641D1 (de)	2011-04-14
ZA200602440B (en)	2007-09-26
JP5506751B2 (ja)	2014-05-28
WO2005028479A3 (en)	2005-06-16
WO2005028479A2 (en)	2005-03-31
KR20060121878A (ko)	2006-11-29
CN1856496A (zh)	2006-11-01
US20060293330A1 (en)	2006-12-28
US8026245B2 (en)	2011-09-27
CA2535313C (en)	2012-07-17
CN100475815C (zh)	2009-04-08
JP2012006945A (ja)	2012-01-12
EA009734B1 (ru)	2008-02-28
MXPA06002069A (es)	2006-05-19
AP2006003517A0 (en)	2006-02-28
JP2007506707A (ja)	2007-03-22
EP1668011B1 (en)	2011-03-02
CA2535313A1 (en)	2005-03-31
IL174467A0 (en)	2006-08-01
AU2004274185B2 (en)	2009-12-10

Publication	Publication Date	Title
NO20061788L (no)	2006-04-24	HIV-replikasjonshemmede purinderivater
GB0612423D0 (en)	2006-08-02	Therapeutic agents
NO20054905L (no)	2006-01-25	2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
NO20021328L (no)	2002-05-21	Pyrazolopyrimidier som terapeutiske midler
NO20060974L (no)	2006-04-27	Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20060981L (no)	2006-05-02	Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20060973L (no)	2006-04-27	Pyridylderivater og deres anvendelse som tempeutiske midler
TW200630344A (en)	2006-09-01	Tetracyclic indole derivatives as antiviral agents
CY1105362T1 (el)	2010-03-03	Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
NO20054143L (no)	2005-09-06	Pyrimidinderivater for forhindringen av HIV-infeksjon
DE602004024375D1 (de)	2010-01-14	Carboxamidderivate
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
TR200302242T2 (tr)	2004-12-21	Protein kinaz önleyicileri olarak pirolopirimidinler
CY1109497T1 (el)	2014-08-13	Παραγωγα θειοφενιου ως αντιβιοτικοι παραγοντες για λοιμωξη/μολυνση φλαβοϊου (flavivirus)
NO20081844L (no)	2008-05-29	Terapeutiske forbindelser
GB0413087D0 (en)	2004-07-14	Therapeutic compounds
NO20072515L (no)	2007-06-28	2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
AU2003291885A1 (en)	2004-06-30	Compounds and methods for the treatment or prevention of flavivirus infections
WO2006027628A3 (en)	2006-05-04	Naphthalimide derivatives as antiviral agents
MXPA04005156A (es)	2004-08-11	Antagonistas del receptor de adenosina a2a.
NO20070837L (no)	2007-04-16	Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
NO20062491L (no)	2006-09-06	Benzoksazinderivter og deres anvendelse
NO20050088L (no)	2005-01-06	Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
TNSN04203A1 (en)	2007-03-12	Benzoxazinone-derived compounds, their preparation and use as medicaments
SE0202429D0 (sv)	2002-08-14	Novel Compounds

Legal Events

Date	Code	Title	Description
2008-04-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application